Idiopathic Pulmonary Fibrosis Study
In this study, an investigational medicine is taken at regular intervals over 52 weeks to evaluate the efficacy and safety of the medication in participants who have Idiopathic Pulmonary Fibrosis.
Who are we looking for?
- Established diagnosis of Idiopathic Pulmonary Fibrosis
- Age >40
- Additional criteria not listed here
What’s provided for duration of study:
- Study medication
- Safety testing
- Modest payments for each visit completed
If you would like additional information, please send us an email or give us a call!
Thank you for your interest – we look forward to hearing from you!